European Continental Ancestry GroupPeripheral Blood Stem Cell TransplantationStem CellsHematopoietic Stem Cell TransplantationBone MarrowTransplantation, AutologousHematopoietic Stem CellsHematopoietic Stem Cell MobilizationLeukocyte CountBone Marrow TransplantationBone Marrow CellsGranulocyte Colony-Stimulating FactorLeukapheresisBlood CellsTransplantation, HomologousStem Cell TransplantationBlood Cell CountCord Blood Stem Cell TransplantationAntigens, CD34Blood Component RemovalLeukocytesEmbryonic Stem CellsTransplantation ConditioningAdult Stem CellsGraft vs Host DiseaseHematopoiesisHematologic NeoplasmsMelphalanCell DifferentiationCyclophosphamideGraft SurvivalPluripotent Stem CellsCombined Modality TherapyStem Cell NicheBone Marrow DiseasesTreatment OutcomeMultiple MyelomaFetal BloodAntineoplastic Combined Chemotherapy ProtocolsColony-Forming Units AssayPlatelet CountBusulfanStem Cell FactorNeural Stem CellsInduced Pluripotent Stem CellsWhole-Body IrradiationTime FactorsErythrocytesMesenchymal Stem Cell TransplantationFlow CytometryRemission InductionMultipotent Stem CellsLeukemiaCell LineageCells, CulturedBone Marrow PurgingCell SeparationRecurrenceTissue DonorsErythrocyte CountTransplantation ChimeraLeukemia, Myeloid, AcuteLymphoma, Non-HodgkinEtoposideRetrospective StudiesAntineoplastic Agents, AlkylatingMesenchymal Stromal CellsBiological MarkersInfectionLeukocytosisHistocompatibilityThiotepaGranulocytesCytarabineAnemia, AplasticMice, Inbred C57BLMyeloablative AgonistsImmunophenotypingHematologic DiseasesAntigens, CDRecombinant ProteinsHistocompatibility TestingSurvival AnalysisBlood DonorsSurvival RatePrecursor Cell Lymphoblastic Leukemia-LymphomaDisease-Free SurvivalCell CountHematologic TestsProspective StudiesAcute DiseaseNeoplasmsImmunosuppressive AgentsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCell ProliferationPrognosisVincristineFollow-Up StudiesBone Marrow ExaminationStem Cell Research